ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,321Medicare Part D Prescriptions Filled, Including Refills

Rank: 84 out of 1802

$482K Total Retail Price of All Prescriptions

Rank: 103 out of 1802

328 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
42% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 328 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

19% of this provider’s 328 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 8,036 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
LEVOTHYROXINE SODIUM 415 341 1 2
SIMVASTATIN 298 262 2 1
OMEPRAZOLE 293 244 3 4
HYDROCODONE-ACETAMINOPHEN 280 224 S3 4 10
FUROSEMIDE 269 250 5 5
METFORMIN HCL 229 215 6 11
AMLODIPINE BESYLATE 223 194 7 6
DONEPEZIL HCL 212 212 8 26
WARFARIN SODIUM 210 198 9 7
BUMETANIDE 210 186 9 102
METOPROLOL TARTRATE 196 161 11 9
POTASSIUM CHLORIDE 185 160 12 15
CITALOPRAM HBR 168 135 13 17
LISINOPRIL 158 157 14 3
MELOXICAM 140 99 15 59
NAMENDA 138 138 16 34
PANTOPRAZOLE SODIUM 137 107 17 44
MIRTAZAPINE 120 120 18 38
ATENOLOL 114 102 19 12
PREDNISONE 109 106 20 33
METOPROLOL SUCCINATE 104 82 21 13
QUETIAPINE FUMARATE 97 87 22 54
PRAVASTATIN SODIUM 94 83 23 19
POLYETHYLENE GLYCOL 3350 92 90 24 29
HYDROCHLOROTHIAZIDE 91 87 25 8
DIVALPROEX SODIUM 88 88 26 74
CLOPIDOGREL 84 84 27 48
BENAZEPRIL HCL 83 79 28 61
LISINOPRIL-HYDROCHLOROTHIAZIDE 70 66 29 23
GABAPENTIN 69 51 30 16
TAMSULOSIN HCL 66 66 31 28
ALENDRONATE SODIUM 65 57 32 21
FENOFIBRATE 63 58 33 56
LOSARTAN POTASSIUM 63 50 33 18
SERTRALINE HCL 62 46 35 20
CLONIDINE HCL 62 51 35 77
LOSARTAN-HYDROCHLOROTHIAZIDE 60 50 37 52
ATORVASTATIN CALCIUM 60 58 37 14
TRAMADOL HCL 55 46 39 22
CARBIDOPA-LEVODOPA 54 54 40 70
VERAPAMIL ER 52 40 41 111
METOLAZONE 51 46 42 175
DIGOXIN 50 50 43 45
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 11, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.